DEC 18, 2020 5:00 AM PST

A new approach of COVID-19 surveillance testing to maximize the identification of asymptomatic patients

Sponsored by: DiaSorin
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Associate Professor and Head of the Unit of Microbiology The Greater Romagna Area Hub Laboratory DIMES - University of Bologna
    BIOGRAPHY

Abstract

Date:  December 18, 2020

Time: 5:00am PST, 2:00pm CET

 

Europe continues to battle a second wave of COVID19 epidemic; more than 30.000 newly infected patients are being confirmed daily in Italy. As of November 16th, 27,687 individuals have been infected with SARS-CoV-2 in Italy, of whom 600 have passed away. The World Health Organization (WHO) has raised a global warning and announced the need for a test system for COVID-19- suspected patients (World Health Organization, 2020). SARS-CoV-2 is known to be spread even by infected people who experience only mild symptoms or are asymptomatic carriers (Li etal.,2020;Baietal., 2020; Rothe et al., 2020). Therefore, there is a need to expand testing capacity also to asymptomatic individuals to stop transmission. In routine clinical practice, SARS-CoV-2 infection is determined by reverse-transcription PCR (RT-PCR) analysis (Corman et al., 2020). The RT-PCR test is conducted using different types of specimens, including sputum, nasopharyngeal swabs, pharyngeal swabs, saliva, stool, bronchoalveolar lavage fluid, and endotracheal aspirate fluid (KK-W et al., 2020; To et al., 2020; Wang et al., 2020). However, the RT-PCR test is not rapid (it typically takes 3–4 h for results), and it requires specialized laboratory equipment and skilled technicians, while antigen tests are simple and can be performed routinely in clinical laboratories (Lai et al., 2020; Clerc and Greub, 2010). New more cost-effective and high throughput test system will be important for preventing viral spread and monitoring infection levels in COVID-19 patients. Here, we are presenting a newly approach of Covid-19 testing that will be used as a filter, by identifying, isolating, and thus filtering out currently infected persons, including those who are asymptomatic. This is a new regimen of testing to detect frequently the asymptomatic infected persons, which are primary source of transmission.

 

Learning Objectives:

  • To assess the use of Antigen assay in screening of asymptomatic COVID-19 individuals
  • To demonstrate the impact of a new regimen of COVID-19 testing
  • To evaluate whether the new screening approach is cost-effective

 

 

Webinars will be available for unlimited on-demand viewing after live event.

 

LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
APR 21, 2021 10:00 AM PDT
C.E. CREDITS
APR 21, 2021 10:00 AM PDT
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
OCT 27, 2021 8:00 AM PDT
C.E. CREDITS
OCT 27, 2021 8:00 AM PDT
Date: October 27, 2021 Time: 8:00am (PDT), 11:00am (EDT) Learn about how brightfield images can take your flow cytometry data to the next level. Join Dr. Cora Chadick, Technical Director, as...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
DEC 18, 2020 5:00 AM PST

A new approach of COVID-19 surveillance testing to maximize the identification of asymptomatic patients

Sponsored by: DiaSorin
C.E. Credits: P.A.C.E. CE Florida CE

Specialty

Laboratory Testing

Microbiology

Infectious Disease

Molecular Biology

Immunology

Clinical Diagnostics

Molecular Diagnostics

Disease

Health

Research And Development

Clinical Medicine

Genetics

Research

Molecular Genetics

Cancer Research

Geography

North America54%

Europe26%

Asia13%

South America3%

Africa2%

Oceania1%

Registration Source

Website Visitors65%

WAVE Newsletter Promotion14%

Email Promotions10%

Labroots Registration (Also interested in)7%

Trending Newsletter Promotion2%

Website Banners1%

Job Title

Medical Laboratory Technician26%

Facility/Department Manager11%

Clinical Laboratory Scientist9%

Student9%

Lab Management7%

Executive6%

Medical Doctor/Specialist6%

Biologist5%

Educator/Faculty5%

Research Scientist4%

Microbiologist4%

Scientist3%

Chemist2%

Marketing/Sales2%

Consultant1%

Other1%

Organization

Hospital22%

Clinical Laboratory21%

Academic Institution12%

Diagnostic Company6%

Biotech Company5%

Government3%

General Laboratory3%

Medical Center3%

Independent Laboratories2%

Medical Device Company2%

Research Institute2%

Distribution/sales2%

Industrial Company1%

Government/public1%

Other3%


Show Resources
Loading Comments...
Show Resources